Showing results (1311-1320 of 2,791) with videos related to
Sort By:
Pageof 280
Cytotherapy|December 12, 2024
TissueGene-C induces anti-inflammatory activity and M2 macrophage polarization via activation of prostaglandin E<sub>2</sub> signalingHuan Tran, Wilma Tauro, Ali Mobasheri, et al.Cytotherapy|February 7, 2025
A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteersNisha Suyien Chandran, Monil Nagad Bhupendrabhai, Thong Teck Tan, et al.Cytotherapy|February 1, 2025
Sickle cell disease gene therapy drug expenses and reimbursement: a litmus test for commercial pricing strategy and patient access for curative therapiesBambi J Grilley, Ashley Hume, Jacques GalipeauCytotherapy|February 3, 2025
Ganglioside expression delineates human mesenchymal stem/stromal cell populations derived from different tissue sourcesSophie Groux-Degroote, Kyle Martin, Nao Yamakawa, et al.Cytotherapy|January 26, 2025
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cellsKatarina Le Blanc, Francesco Dazzi, Karen English, et al.Cytotherapy|February 19, 2025
Fellowship training for cellular therapy laboratory directorsAshley A Krull, Margaret A DiGuardo, Michael C Deeds, et al.Cytotherapy|January 8, 2025
Smart Cell Therapy: an industry perspective on macrophages as living drugsDavid T Rodgers, Tatiana Novobrantseva, Rita N BarciaCytotherapy|January 5, 2025
Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamideAlexander Nikoloudis, Anna Bauhofer, Lena Griessl, et al.Cytotherapy|December 9, 2024
Beyond precision: evaluation of off-target clustered regularly interspaced short palindromic repeats/Cas9-mediated genome editingIrene Peña-Gutiérrez, Beatriz Olalla-Sastre, Paula Río, et al.Cytotherapy|December 3, 2024
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remissionYoshimitsu Shimomura, Tetsuhisa Kitamura, Masamitsu Yanada, et al.Pageof 280